DelveInsight Blogs Sitemap

All Posts in this category
S.No. Product Name Actions
1 Asahi Intecc Partners with Penumbra; Prosoma and EVERSANA Announce Commercialisation Partnership; Zynex Starts Enrollment in the Blood Loss Detection Clinical Trial; Reva Initiates Enrollment in the MOTIV IDE Clinical Trial; FDA Clearance to QT Imaging to Calculate Fibroglandular Volume of the Breast; FDA 510k Clearance to iMediSync’s EEG scanner ‘iSyncWave’ Visit Post
2 Aerin Medical’s RhinAer Stylus; CE Mark for Haemonetics’s VASCADE Vascular Closure Device; J&J Vision Launches ACUVUE OASYS MAX 1-Day; Olympus Launches VISERA ELITE III Surgical Visualization Platform; GlucoRx’s Non-Invasive Glucose Monitoring Platform; Medtronic-BioIntelliSense’s Partnership; Corindus’s CorPath GRX Neurovascular System Trial; GE & Lantheus [18F]flurpiridaz PET Radiotracer Trial; Pulmonx’s AeriSeal System Trial; AtriAN’s Second Study on Cardioneuroablation Visit Post
3 Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia Visit Post
4 AAV Vectors in Gene Therapy: How Recent Clinical Advances are Unraveling New Potentials? Visit Post
5 Rapid Medical’s TIGERTRIEVER 13; Glaukos’s Istent Infinite System; GE Healthcare’s Definium 656 HD; NeuroOne’s Signed Exclusive Development & Distribution Agreement with Zimmer; Kaia Health’s Rise-uP Randomized Controlled Trial; Bluejay’s Symphony IL-6 Test Visit Post
6 FDA Clearance to iRhythm’s ZEUS System; Respiri Introduces the Wheezo Device & App; CONMED to Acquire Biorez for $ 85 Million; FDA Clearance to Ambu’s Single-Use Bronchoscope; FDA 510(k) Clearance to Glaukos’s iStent infinite Visit Post
7 AbbVie & iSTAR’S Strategic Alliance; Baxter Launches Welch Allyn RetinaVue 100 Imager PRO; Instylla’S Embrace Hydrogel Embolic System; Primary Endpoint Met in the RADIANCE II US Trial; Roche's Elecsys Amyloid Plasma Panel; EU Approval to Seegene’s Allplex; SARS-CoV-2/FluA/FluB/RSV Assay Visit Post
8 A Market Space Beyond Lucentis and Eylea for Retinal Vein Occlusion Treatment Visit Post
9 LumiThera’s US LIGHTSITE III Trial; First Patient Enrolled in Vascular Closure Device Study of Teleflex; Varian’s Flash Technology Clinical Trial, FAST-02; 3Spine’s MOTUS Device; Illumina’s Research Test to Detect Tumor Genome; Acutus Medical's AcQCross Qx System Visit Post
10 Aurora Spine’s Interbody Fusion Device; LENSAR’s ALLY Adaptive Cataract Treatment System; Abbott's Mitral & Tricuspid Heart Valve Devices; Boston Scientific’s Acurate Neo2 Aortic Valve System Study; Resolution Medical Acquired Lifetec Group; Paragon 28’s Monkey Rings External Fixation System Visit Post
11 Diabetic Retinopathy: The Hornet’s Nest of Diabetes Mellitus Visit Post
12 Dry AMD Market: Pegcetacoplan or Zimura, Which Therapy Will Dominate the Market? Visit Post
13 Abbott’s Alinity m STI Assay; Phillips’ MR 7700 System; HOYA’s MiYOSMART Spectacle Lens; Magneto’s Pulmonary Embolism Treatment; Owen Mumford and Stevanto Group’s Collaboration Deal; Elekta’s Radiosurgery System-Elekta Esprit Visit Post
14 Rise In Bispecific Antibodies Utilization As Antibody Therapeutics Visit Post
15 Global Top Players in Intraocular Lens (IOL) Market Visit Post
16 Prominent Players in Glaucoma Drainage Devices Market Visit Post
17 Alcon’s Dry Eye Treatment Device; I-VASC Secures Series A Funding; Paige’s AI Medical Device Software; TRUVIC’s Prodigy Thrombectomy System; Alucent’s Natural Vascular Scaffolding Technology; Guardant Presents Data Supporting Efficacy of Blood Test in Detecting Multiple Cancers Visit Post
18 Analyzing the Most Promising Drugs That Will Lose Patent in the US & EU in 2022 Visit Post
19 NeuroLogica’s OmniTom Elite; Cordis’s S.M.A.R.T. RADIANZ Vascular Stent System; Rockley Photonics and Medtronic’s Collaboration; NovaSight’s Amblyopia Treatment Device; Cardiawave’s VALVOSOFT; OSF Ventures invests in wireless seizure detection sensor Visit Post
20 Motus GI’s Pure-Vu EVS System; EvoEndo’s Single-Use Unsedated TNE System; Orthofix’s OpusTM BA; Invitae’s CE-IVD Cancer Testing Kits; PolyActiva’s PA5108 Ocular Implant; Ra Medical’s DABRA excimer laser system Visit Post
21 Immunocore’s Kimmtrak; Samsung Acquires Biogen's Biosimilar Unit; Novavax’s COVID-19 Vaccine; CHMP Approves Dupixent (dupilumab); Glenmark’s High Blood Pressure Treatment; Roche’s Faricimab; GBT’s Voxelotor Visit Post
22 Leman Micro Devices’ e-Checkup system; Calon Cardio-Technology & Leviticus-Cardio announced Breakthrough; Alcon buys Ivantis; Medtronic to acquire Affera; Abiomed’s Impella 5.5 with SmartAssist; Abbott’s EnSite X EP System with EnSite OT Visit Post
23 Cerner, Scanwell Health and Personal Genome Diagnostics Acquisition; Zynex's Fluid Monitoring System, CM-1500; Sight Sciences' TearCare System; Envista's Nobel Biocare N1 Implant System Visit Post
24 Edwards’ Sapien 3 with Alterra Prestent; Koios Medical’s breast, thyroid cancer-spotting AI; Lineage Collaborates with Genentech; Novartis, BeiGene ink deal Visit Post
25 Analyzing the Growth of the Biosimilar Market Through Years Visit Post
26 LensGen’s Juvene Intraocular Lens; Nevro announces clinical data publications; FDA Clearance to Immunexpress’s SeptiCyte; GE unveils AI and Digital Technologies; Canon launches PIQE DLR and SilverBeam; Hyperfine’s Swoop gets FDA clearance Visit Post
27 Neurent Medical’s NEUROMARK; Brain Navi NaoTrac received European CE Mark approval; Theradaptive receives Breakthrough Medical Device Designation; HAGAR GWave awarded Breakthrough Device Designation; Fujifilm launches ColoAssist PRO Visit Post
28 Abbott's Pacemaker System; Ivantis’s Hydrus Microstent; Medtronic’s PillCam Small Bowel 3; ALung Technologies's Hemolung; AppliedVR’s EaseVRx; J&J to split into two companies; OrthAlign’s Lantern® launch; LumiThera’s Light-based Theranostic Visit Post
29 AstraZeneca-Moderna's AZD8601 VEGF-A mRNA Trial; Wision AI gets CE Mark approval; Getinge acquires Verrix; LumiThera buys Diopsys Visit Post
30 TecTraum’s pro2cool receives Breakthrough Device Designation; Vektor Obtains FDA Clearance for vMap; Medtronic’s TMVR system; Sight Sciences's PRECISION Trial; Alcon to buy Ivantis; Philips to acquire Cardiologs Visit Post
31 Alcon to acquire Ivantis; Philips to takeover Cardiologs; Flunked cancer drug progresses in I-O in pancreatic cancer models; Indigo system CAT RX catheter meets primary endpoint in trial Visit Post
32 An in-depth Assessment of the Top Drugs Launched by Leading Global Companies in the First Half of 2021 (H1) Visit Post
33 FDA 510k clearance to Naviswiss's Naviplan; FDA approved to TYRVAYA; Centinel Spine's STALIF Integrated Interbody System; Smith+Nephew's IODOSORB; AlloSource's AlloMend Extra-Large ADM; SpinaFX and StarFish's strategic commercialisation contract Visit Post
34 Ocular Therapeutix’s insert fails in phase 2; Click Therapeutics raises $52M funding; Roche introduces AVENIO Tumour Tissue CGP Kit; Blue Wolf Capital to acquire CIVCO Radiotherapy Visit Post
35 von Willebrand disease (VWD) – Misdiagnosis Still Prevalent! Visit Post
36 Bausch + Lomb's LuxSmart Intraocular Lenses; Movair's Luisa Life Supporting Ventilator; Cochlear's Nucleus and Baha Systems; Laborie Acquires Pelvalon; Know Labs's SARS-CoV-2 Research; Syntellix's MAGNEZIX; Visit Post
37 Biogen’s AMD Biosimilar Gets Approval; SmartLabs Series B Funding; BARDA, Partner Therapeutics in Sepsis Space; Synlogic to Explore Sepsis Market Domain Visit Post
38 FDA’s New Drug Application to ALS Drug; Approval to BeiGene’s Brukinsa; Roche, Temedica Forges Digital Companionship, Shares of Sage Therapeutics Rises Visit Post
39 Duchenne Muscular Dystrophy Market: What's More Beyond Exon-Skipping Therapies? Visit Post
40 New Approaches and Evolutions to Reshape the Diabetes Management and Care Visit Post
41 LQTT secures $19M; Nanox acquires Zebra Medical Vision; Takeda leads IBD drug; Visus raises $20M Visit Post
42 Nevro's Spinal Cord Stimulation; Boston's PINNACLE FLX; NuVasive's Modulus ALIF; J&J's VERITAS Vision System; Medtronic's DCB Catheter; AngelMed's Heart Attack Warning System Visit Post
43 Unity's advanced vascular eye disease trial; Rallybio raises $100 M; Sanofi bets over $1B for Eureka's candidate; Lilly invests in MiNA; Visit Post
44 How will Pharmacotherapies help the growing number of Presbyopes? Visit Post
45 Age-related Hearing Loss Device Market Dynamics Expected to Step into Growth Quadrant Visit Post
46 How Pharmaceutical Companies Are Mitigating The Gap In The Eye Disorders Treatment Market Visit Post
47 MedTech Industry Roars Back as FDA Approvals Soar Visit Post
48 Bluebird suspends gene therapy trials; Cortexyme tripped up by FDA hold; Guardant Health launches surveillance blood test; Enhertu scores approval Visit Post
49 Increasing Prevalence and Upcoming Novel Therapeutic Approaches: What is Shaping the Hepatitis D Market Outlook? Visit Post
50 8 Of The Most Common Foods Allergies - Do You Have One? Visit Post
51 Roche's quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study Visit Post
52 Top Emerging Therapies To Watch Out for in the Retinal Vein Occlusion Market Visit Post
53 What are the options available for the treatment of Retinal vein occlusion? Visit Post
54 Keratoconus - Rare? Not really! Visit Post
55 An Eye-Blinding Scenario of Vernal keratoconjunctivitis Visit Post
56 Mapping The Pipeline Development In The Geographic Atrophy Market Visit Post
57 One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline Visit Post
58 What is driving Retinitis pigmentosa market forward? Visit Post
59 Retinitis Pigmentosa: A complex disease, and the increasing gap between prevalence and diagnosed prevalence Visit Post
60 Promising therapies that might shift Wet Age-related Macular Degeneration Market in the next decade Visit Post
61 Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D Visit Post
62 Thyroid awareness month Visit Post
63 Thyroid eye disease market: New therapies enter the TED market Visit Post
64 Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter Visit Post
65 Geographic Atrophy Treatment Market: Novel Therapies to Enter the Market Visit Post
66 Boehringer Ingelheim ties up with Inflammasome Therapeutics Visit Post
67 Daiichi Sankyo fuels commercialization of DS-8201 in Japan; Roivant Sciences transfers its biotech stake for USD 3 Billion; FDA, EMA accepts marketing of Allergan’s abicipar Visit Post
68 Vertex acquires Semma; Luxturna gets approval for rare eye disorder Visit Post
69 Allergic Conjunctivitis Therapy Market and Pipeline Analysis Visit Post
70 Leber Hereditary Optic Neuropathy Treatment Market Visit Post
71 Cataract Awareness Month Visit Post
72 AstraZeneca-Daiichi’s results; Novartis remunerates; Pfizer to acquire Therachon; Gilead & Goldfinch Bio collaboration Visit Post
73 Japan has got new ways to treat corneas Visit Post
74 World Glaucoma Week Visit Post
75 Notizia Visit Post
76 Antidepressant of J&J leads to FDA; SCLC model discloses; Genes and macular degeneration can disclose new treatment ways Visit Post
77 Notizia Visit Post
78 Notizia Visit Post
79 Ceribell raises $35M; Lyra reels $29.5M; Minoryx raises Euro21M; Alexion acquired Syntimmune Visit Post
80 Atreca secured $125M; OncoResponse bags $40M; Kodiak Sciences’s IPO; Biodesy contemplates $20M Visit Post
81 Commercial Visit Post
82 Commercial Outcomes - Novartis Visit Post
83 Allergic Conjunctivitis (AC)- Market Insights, Epidemiology and Market Forecast- 2027 Visit Post
84 Allergic Conjunctivitis (AC) – Common disorder with increasing prevalence Visit Post
85 Business Cocktail Visit Post
86 Retinal Degeneration : The Current Pipeline Scenario Visit Post
87 Snippet Visit Post
88 Wet AMD: A chronic eye condition with promising therapies Visit Post
89 Medical tourism in India Visit Post
90 Clinigen and Eisai team up; Sanofi, Lonza enter; Fidia to acquire; J&J completes acquisition Visit Post
91 Prosecutors rope Pfizer; Pharma groups to FDA; Regeneron simulates; Otsuka & Lundbeck revive;Philidor execs plead Visit Post
92 PMV Raises; Argos Shares Plummet; Cidara Flunks in; Sarepta Sells to Gilead; Novartis and NHS Ayrshire & Arran launch Visit Post
93 USFDA warns; Vit B3 prevents glaucoma; Zydus Cadila receives nod; U.S. experts soften on DNA editing Visit Post
94 U.K. weighs drug rationing; Applying Digital; FDA slaps Florida Visit Post
95 Anterior Uveitis: A Vision-threatening condition Visit Post
96 Novartis eyes; Pfizer considers cashing; Mylan pushes to seal $465M; Valeant with Takeda for deal Visit Post
97 Bayer Partners with DelSiTech to Develop; Amgen and Arrowhead Announce; Allergan, AstraZeneca’s deal; Lexicon Pharma announces deal Visit Post
98 DelveInsight’s Ophthalmologic disorders based Gene Therapy Reports Visit Post